- Home
- EXFY vs AKYA Comparison
EXFY vs AKYA Comparison
Compare EXFY & AKYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXFY
- AKYA
- Stock Information
- Founded
- EXFY 2008
- AKYA 2015
- Country
- EXFY United States
- AKYA United States
- Employees
- EXFY N/A
- AKYA N/A
- Industry
- EXFY Computer Software: Prepackaged Software
- AKYA Medical Specialities
- Sector
- EXFY Technology
- AKYA Industrials
- Exchange
- EXFY Nasdaq
- AKYA Nasdaq
- Market Cap
- EXFY 150.3M
- AKYA 145.5M
- IPO Year
- EXFY 2021
- AKYA 2021
- Fundamental
- Price
- EXFY $2.93
- AKYA $3.13
- Analyst Decision
- EXFY Hold
- AKYA Buy
- Analyst Count
- EXFY 5
- AKYA 9
- Target Price
- EXFY $2.63
- AKYA $6.08
- AVG Volume (30 Days)
- EXFY 682.8K
- AKYA 98.9K
- Earning Date
- EXFY 11-07-2024
- AKYA 11-14-2024
- Dividend Yield
- EXFY N/A
- AKYA N/A
- EPS Growth
- EXFY N/A
- AKYA N/A
- EPS
- EXFY N/A
- AKYA N/A
- Revenue
- EXFY $137,440,000.00
- AKYA $93,216,000.00
- Revenue This Year
- EXFY N/A
- AKYA $3.66
- Revenue Next Year
- EXFY $7.39
- AKYA $18.18
- P/E Ratio
- EXFY N/A
- AKYA N/A
- Revenue Growth
- EXFY N/A
- AKYA 9.66
- 52 Week Low
- EXFY $1.24
- AKYA $1.88
- 52 Week High
- EXFY $3.00
- AKYA $6.31
- Technical
- Relative Strength Index (RSI)
- EXFY 80.16
- AKYA 57.80
- Support Level
- EXFY $1.82
- AKYA $3.10
- Resistance Level
- EXFY $3.00
- AKYA $3.32
- Average True Range (ATR)
- EXFY 0.17
- AKYA 0.19
- MACD
- EXFY 0.13
- AKYA 0.03
- Stochastic Oscillator
- EXFY 85.71
- AKYA 84.25
About EXFY Expensify Inc.
Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.
About AKYA Akoya BioSciences Inc.
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.